New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body weight after 36 weeks, according to a randomized phase II…
Read the full articleYou might also wanna read
Cryoprobe Improves Diagnostic Accuracy and Safety in Lung Biopsies
news.northwestern.edu·17d ago
Lymphatic Dysfunction Drives Heart Valve Disease
news.northwestern.edu·23d ago
Immune Cell Circuit Restores Barrier Function in IBD
news.northwestern.edu·24d ago
Expanding the Evidence for Behavioral Interventions in Gastroenterology
news.northwestern.edu·25d ago
Bacteria ‘Rewire’ Epithelial Cells and Drive Disease in the Gut
news.northwestern.edu·28d ago
Hormone Impacts Red Blood Cell Production in Anemia
news.northwestern.edu·1mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.